Community Research and Development Information Service - CORDIS

Late Clinical Development of KH176: an innovative orphan drug to reach mitochondrial disease patients & market

From 2018-10-01 to 2020-09-30, ongoing project

Project details

Total cost:

EUR 3 337 525

EU contribution:

EUR 2 336 267,50

Coordinated in:

Netherlands

Call for proposal:

H2020-SMEInst-2018-2020-2See other projects for this call

Funding scheme:

SME-2 - SME instrument phase 2

Objective

Coordinator

KHONDRION BV
Netherlands

EU contribution: EUR 2 336 267,50


VAN HEEMSTRAWEG 49 E
6641 AA BEUNINGEN
Netherlands
See on map
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top